Wernicke Encephalopathy Secondary to Cannabinoid Hyperemesis Syndrome in a 15-Year …
#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
In a 15-year-old patient, Wernicke Encephalopathy was diagnosed secondary to Cannabinoid Hyperemesis Syndrome (CHS). The urine drug screen confirmed THC presence, indicating chronic cannabis use. CHS, characterized by cyclical vomiting and frequent hot bathing, can lead to thiamine depletion due to excessive smoking and poor nutrition. This impairs the body’s metabolism of thiamine, leading to Wernicke Encephalopathy, a neurological disorder marked by confusion, oculomotor abnormalities, and ataxia. Clinicians should be aware of CHS as a potential cause of unexplained vomiting in chronic cannabis users, and consider thiamine supplementation to prevent or manage associated neurological complications.
💊 🧠 In the context of increasing cannabis use and its associated health implications, a noteworthy case of Wernicke Encephalopathy secondary to Cannabinoid Hyperemesis Syndrome (CHS) in a 15-year-old patient serves as a reminder for healthcare providers. This condition, often observed in chronic cannabis users, is characterized by cyclical vomiting and compulsive hot bathing. The diagnosis was confirmed through a positive urine drug screen for THC. It’s crucial to recognize that CHS can lead to nutritional deficiencies, particularly thiamine (vitamin B1), which is essential for brain function. When thiamine is depleted due to prolonged vomiting and poor nutrition, metabolism is unable to occur, leading to Wernicke Encephalopathy. Clinically, this highlights the importance of
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: